Biotechnology for Non-Scientists Courses

Introduction to Genetic Engineering explains the process and the power of genetic engineering. Genetic engineering is the deliberate modification of genetic material (DNA). It is used extensively in research, drug discovery, drug development, and biomanufacturing. Biotechnology is built on genetic engineering; therefore, it is a “must-know” topic for those working in or with the biopharma industry.

Immunology 101 explains how the human immune system fights infectious diseases and cancer. Learn how pathogens cause disease, distinguish between the non-specific and specific immune systems, and understand the critical role of white blood cells. Many of biopharma’s blockbuster biologics are modifications of the molecules and cells used by our immune system, including T-cells, B-cells, antibodies, and cytokine inhibitors. This course is an introductory course designed for those new to immunology.

Immunology 201 builds on Immunology 101 class to describe the two types of immune systems, the non-specific immune system, and the specific immune system. This class puts all the immune system details into practice, taking you on a journey from how disease occurs to how your body fights disease. By understanding this complex process, you will better understand how these steps are exploited by the biopharma industry to create cutting-edge immunotherapies in biotechnology.

Antibodies examine the versatile role of antibodies, including how they are used in research and the clinic. Learn how monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, and checkpoint inhibitors mitigate disease. Understand how common diagnostics such as ELISA, bead immunoassay, and lateral flow immunochromatographic assay use antibodies for testing. Increase your fluency in the science of antibodies and appreciate their importance in today’s healthcare industry.

Biosimilars explain the science, manufacturing technology, and regulatory requirements for receiving approval to market biosimilar products. Beginning with an overview of protein structure, function, and production, the class hones in on different types of biologics and how each mitigates disease. The Manufacturing section highlights how conditions can alter a biosimilar, causing it to function differently than its reference product. The Safety and Regulation section examines immunogenicity and approaches to demonstrating biosimilar safety and efficacy that have been acceptable to the FDA and EMA. The class ends with four case studies demonstrating the real-world complexity of biosimilar science, manufacturing, and regulatory challenges.

Introduction to Gene Therapy provides a foundational understanding of this versatile therapeutic’s science and regulatory process. Learn how gene therapy works—the type of vectors used, and why/when certain vectors are employed. This course reviews the most important factors determining which diseases should be targeted using gene therapy. As with any treatment, there are risks, so Introduction to Gene Therapy explains the FDA approval process and how safety and efficacy are measured. Take Introduction to Gene Therapy and gain a basic understanding of gene therapy.

Cell Therapy Primer explains how cancer poses an immune challenge and the scientific rationale behind designing Chimeric Antigen Receptors (CAR) to address it. It examines the commercial advantages and disadvantages of various cell lines and provides insights into the next generation of cell therapies. Learn the basic science of cell therapy and its potential to transform the future of medicine.

BioBasics 201: Targeted Biologics for the Non-Scientist is an intensive, two-day course focused on vaccines, cell therapies, gene therapies, therapeutic antibodies, and RNA-based drugs. Biopharma’s inspiration for the development of targeted biologics is our own human immune system, so we begin with an in-depth explanation of immunology. The course then focuses on the science, challenges, and medical promise of next-generation targeted biologics. BioBasics 201 is designed for the non-scientist who has taken BioBasics 101 or for those who understand the basics of DNA, RNA, proteins, and cell signaling. BioBasics 201 is taught by industry experts who explain how these complex drugs work in a simple, engaging manner.

Learn More

Gene Therapy Primer explores how gene therapy works, the type of vectors used, and why/when certain vectors are employed. Many believe gene therapy is the key to curing cancer, inherited illnesses, and rare diseases; this course reviews the most important factors determining which diseases should be targeted using gene therapy. As with any treatment, there are risks, so this course looks at the FDA approval process and how safety and efficacy are measured. Take Gene Therapy Primer and gain a foundational understanding of this versatile therapeutics’ science and regulatory environment.

Learn More